Literature DB >> 2162977

Hepatoblastoma in neonates: report of a case and review of the Japanese literature.

M Honzumi1, T Miura, I Fujino, H Suzuki.   

Abstract

A female infant who presented with abdominal distention and jaundice at the age of 2 days underwent resection of a large hepatoblastoma at the age of 8 days by a right trisegmentectomy. Although postoperative adjuvant chemotherapy was not given, the patient is now alive without disease 10 months after surgery. We were able to find only 10 other cases of hepatoblastoma occurring in the newborn period in the Japanese literature. Resection of the tumor was performed in seven of these patients, of whom there were five survivors, one operative death and one death due to tumor recurrence. However, none of the three patients treated conservatively survived. Thus, we suggest that in newborns with hepatoblastoma, resection of the tumor should be performed, if feasible, but believe that postoperative chemotherapy is not necessary for patients whose tumor has been completely resected.

Entities:  

Mesh:

Year:  1990        PMID: 2162977     DOI: 10.1007/BF02470669

Source DB:  PubMed          Journal:  Jpn J Surg        ISSN: 0047-1909


  4 in total

1.  Clear-cell sarcoma of the kidney seen in a 3-day-old newborn.

Authors:  H Suzuki; M Honzumi; Y Itoh; N Umehara; S Moriyama; M Funada
Journal:  Z Kinderchir       Date:  1983-12

2.  Combination chemotherapy for unresectable hepatoblastoma in children.

Authors:  S Ogita; K Tokiwa; T Takahashi; S Imashuku; T Sawada
Journal:  Jpn J Surg       Date:  1987-01

3.  Preoperative chemotherapy for initially unresectable hepatoblastoma in children. Survival in two cases.

Authors:  K Ikeda; S Suita; A Nakagawara; K Takabayashi
Journal:  Arch Surg       Date:  1979-02

4.  Liver tumors in children in the particular reference to hepatoblastoma and hepatocellular carcinoma: American Academy of Pediatrics Surgical Section Survey--1974.

Authors:  P R Exelby; R M Filler; J L Grosfeld
Journal:  J Pediatr Surg       Date:  1975-06       Impact factor: 2.545

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.